A BLOC-1 mutation screen reveals that PLDN is mutated in hermansky-pudlak syndrome type 9

Andrew R. Cullinane, James A. Curry, Carmelo Carmona-Rivera, Carole G Summers, Carla Ciccone, Nicholas D. Cardillo, Heidi Dorward, Richard A. Hess, James G. White, David Adams, Marjan Huizing, William A. Gahl

Research output: Contribution to journalArticlepeer-review

88 Scopus citations


Hermansky-Pudlak Syndrome (HPS) is an autosomal-recessive condition characterized by oculocutaneous albinism and a bleeding diathesis due to absent platelet delta granules. HPS is a genetically heterogeneous disorder of intracellular vesicle biogenesis. We first screened all our patients with HPS-like symptoms for mutations in the genes responsible for HPS-1 through HPS-6 and found no functional mutations in 38 individuals. We then examined all eight genes encoding the biogenesis of lysosome-related organelles complex-1, or BLOC-1, proteins in these individuals. This identified a homozygous nonsense mutation in PLDN in a boy with characteristic features of HPS. PLDN is mutated in the HPS mouse model pallid and encodes the protein pallidin, which interacts with the early endosomal t-SNARE syntaxin-13. We could not detect any full-length pallidin in our patient's cells despite normal mRNA expression of the mutant transcript. We could detect an alternative transcript that would skip the exon that harbored the mutation, but we demonstrate that if this transcript is translated into protein, although it correctly localizes to early endosomes, it does not interact with syntaxin-13. In our patient's melanocytes, the melanogenic protein TYRP1 showed aberrant localization, an increase in plasma-membrane trafficking, and a failure to reach melanosomes, explaining the boy's severe albinism and establishing his diagnosis as HPS-9.

Original languageEnglish (US)
Pages (from-to)778-787
Number of pages10
JournalAmerican Journal of Human Genetics
Issue number6
StatePublished - Jun 10 2011

Bibliographical note

Funding Information:
We appreciate the excellent technical assistance of Roxanne Fischer. We thank Thomas Markello and Hannah Carlson-Donohoe for assistance with SNP arrays and E. Dell'Angelica for supplying the pallidin antibody. This study was supported by the Intramural Research Programs of the National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA. All authors declare no conflicts of interest.


Dive into the research topics of 'A BLOC-1 mutation screen reveals that PLDN is mutated in hermansky-pudlak syndrome type 9'. Together they form a unique fingerprint.

Cite this